150 related articles for article (PubMed ID: 26800111)
1. In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.
Kubo T; Yanagihara K; Seyama T
Chem Biol Drug Des; 2016 Jun; 87(6):811-23. PubMed ID: 26800111
[TBL] [Abstract][Full Text] [Related]
2. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
[TBL] [Abstract][Full Text] [Related]
3. Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.
Kubo T; Yanagihara K; Sato Y; Nishimura Y; Kondo S; Seyama T
Bioconjug Chem; 2013 Dec; 24(12):2045-57. PubMed ID: 24274056
[TBL] [Abstract][Full Text] [Related]
4. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
5. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
[TBL] [Abstract][Full Text] [Related]
6. Dicer-labile PEG conjugates for siRNA delivery.
Kow SC; McCarroll J; Valade D; Boyer C; Dwarte T; Davis TP; Kavallaris M; Bulmus V
Biomacromolecules; 2011 Dec; 12(12):4301-10. PubMed ID: 22053777
[TBL] [Abstract][Full Text] [Related]
7. Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing.
Abe M; Suzuki H; Nishitsuji H; Shida H; Takaku H
FEBS Lett; 2010 Oct; 584(20):4313-8. PubMed ID: 20869963
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of palmitic acid-conjugated DsiRNA for colon cancer in a mouse subcutaneous tumor model.
Kubo T; Nishimura Y; Hatori Y; Akagi R; Mihara K; Yanagihara K; Seyama T
Chem Biol Drug Des; 2019 Apr; 93(4):570-581. PubMed ID: 30560565
[TBL] [Abstract][Full Text] [Related]
9. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
11. [The effect of silencing Dicer by small interference RNA on the biological characteristics of human glioma cells].
Zhang AL; Kang CS; Han L; Wang GX; Jia ZF; Pu PY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):521-4. PubMed ID: 19806572
[TBL] [Abstract][Full Text] [Related]
12. Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus.
Romanovskaya A; Paavilainen H; Nygårdas M; Bamford DH; Hukkanen V; Poranen MM
PLoS One; 2012; 7(11):e51019. PubMed ID: 23226452
[TBL] [Abstract][Full Text] [Related]
13. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
[TBL] [Abstract][Full Text] [Related]
14. HCV core protein interacts with Dicer to antagonize RNA silencing.
Chen W; Zhang Z; Chen J; Zhang J; Zhang J; Wu Y; Huang Y; Cai X; Huang A
Virus Res; 2008 May; 133(2):250-8. PubMed ID: 18325616
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Dicer Knockout on RNA Interference Using Various Dicer Substrate Small Interfering RNA (DsiRNA) Structures.
Song MS; Alluin J; Rossi JJ
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327991
[TBL] [Abstract][Full Text] [Related]
16. A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes.
Flemr M; Malik R; Franke V; Nejepinska J; Sedlacek R; Vlahovicek K; Svoboda P
Cell; 2013 Nov; 155(4):807-16. PubMed ID: 24209619
[TBL] [Abstract][Full Text] [Related]
17. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
[TBL] [Abstract][Full Text] [Related]
18. siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA.
Galka-Marciniak P; Olejniczak M; Starega-Roslan J; Szczesniak MW; Makalowska I; Krzyzosiak WJ
Biochim Biophys Acta; 2016 Apr; 1859(4):639-49. PubMed ID: 26921501
[TBL] [Abstract][Full Text] [Related]
19. Branched RNA nanostructures for RNA interference.
Nakashima Y; Abe H; Abe N; Aikawa K; Ito Y
Chem Commun (Camb); 2011 Aug; 47(29):8367-9. PubMed ID: 21691656
[TBL] [Abstract][Full Text] [Related]
20. Single-pot enzymatic synthesis of Dicer-substrate siRNAs.
Guiley KZ; Pratt AJ; MacRae IJ
Nucleic Acids Res; 2012 Mar; 40(5):e40. PubMed ID: 22189103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
